anonymous
Guest
anonymous
Guest
Lilly is just waiting for the mass exodus so they won’t have to layoff.
perhaps a VERP offering would be an incentive to departLilly is just waiting for the mass exodus so they won’t have to layoff.
This has long been the case. I have a few friends and two relatives in different parts of the country. Across the board access is horrible. It seems to be particularly bad in areas with big academic centers.I don’t think anyone would argue this isn’t ultimately going to happen; the question is when? The general consensus is around 4th qrt 2026.
time to try another company nowcuts definitely coming....DT only wants reps to call on providers who write 0...
please share timeline...is it cuts in 2025? or 2026? I think every 2 years is the new NORM.
which area?This has long been the case. I have a few friends and two relatives in different parts of the country. Across the board access is horrible. It seems to be particularly bad in areas with big academic centers.
I've long thought that they keep our massive field force in place in order to have tons of money in the "expenses" column. It makes no sense otherwise.
WhenCMH is not done. Too many still . This year. More reductions
agree. if anything, it will be natural attrition due to unbearable pressure, stress and burnout. and that way they don't have to post in any layoffsLilly is just waiting for the mass exodus so they won’t have to layoff.
It’s it is all over the placeThis has long been the case. I have a few friends and two relatives in different parts of the country. Across the board access is horrible. It seems to be particularly bad in areas with big academic centers.
I've long thought that they keep our massive field force in place in order to have tons of money in the "expenses" column. It makes no sense otherwise.
Not.going.to.happen…Seriously though, Lilly has 2 blockbuster product launches taking place within CMH in the next 2 years (orforglipron & retatrutide), so a sales force reduction will not be happening anytime soon; if anything, the sales force will expand.Bring it on. Eliminate at least 1/3 of the CMH division
Keep your head buried in the sand. CMH will be weeded out and reduced.Not.going.to.happen…Seriously though, Lilly has 2 blockbuster product launches taking place within CMH in the next 2 years (orforglipron & retatrutide), so a sales force reduction will not be happening anytime soon; if anything, the sales force will expand.
Needs to happen. Sadly.Keep your head buried in the sand. CMH will be weeded out and reduced.
How many Syneos reps selling Zepbound?Agree. Now syneos will be promoting Zepbound. What a waste
Agree with some of this. LVA worthless in our area. Ask us for info and copy to documents for their bosses. What a joke for the money they are paid. Delete. Tons of CMH with nowhere to go. Delete some. Oncology . No access in half their accounts. Reduce again. Please use more to get accountability in no access markets with the need for people. Medical make “interactions” but do they? More to be done.Access is NOT worse. This is a myth created by anti rep leaders to develop a following. Access is bad or good in areas and has not changed much. It’s much better in southern states. World of difference. We can see people all day every day and they will spend a lot of time with us. Reps with access who are good at the job are the busiest and most stretched in the entire company. Field medical has done NOTHING for years. They barely work at all. LVA is pretty busy but varies. Sales reps are either slammed or in areas with no access and not needed. We need to use brain cells and stop the madness.